Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 139.90%236.33M | -61.61%157.57M | -55.22%98.51M | -77.07%410.46M | -73.76%219.97M | 391.59%1.79B | 288.28%838.31M | 4.72%364.19M | -0.39%215.91M | -72.16%347.77M |
| Operating income | 139.90%236.33M | -61.61%157.57M | -55.22%98.51M | -77.07%410.46M | -73.76%219.97M | 391.59%1.79B | 288.28%838.31M | 4.72%364.19M | -0.39%215.91M | -72.16%347.77M |
| Cost of sales | -89.68%-136.5M | 70.78%-109.16M | 65.20%-71.96M | 78.51%-373.53M | 74.58%-206.77M | -477.23%-1.74B | -367.79%-813.32M | -16.03%-301.08M | -3.77%-173.87M | 74.79%-259.49M |
| Operating expenses | -89.68%-136.5M | 70.78%-109.16M | 65.20%-71.96M | 78.51%-373.53M | 74.58%-206.77M | -477.23%-1.74B | -367.79%-813.32M | -16.03%-301.08M | -3.77%-173.87M | 74.79%-259.49M |
| Gross profit | 276.06%99.83M | 31.07%48.41M | 101.04%26.55M | -29.49%36.93M | -47.17%13.21M | -17.00%52.38M | -40.55%24.99M | -28.51%63.11M | -14.54%42.04M | -59.81%88.28M |
| Selling expenses | -19.21%-10.33M | 21.64%-15.48M | 46.17%-8.66M | 52.75%-19.76M | 24.84%-16.09M | -40.81%-41.81M | -114.74%-21.41M | -8.37%-29.69M | 28.06%-9.97M | 49.82%-27.4M |
| Administrative expenses | -236.20%-34.07M | 14.82%-23.58M | 30.01%-10.14M | 25.01%-27.68M | 20.25%-14.48M | -6.90%-36.92M | -23.90%-18.16M | 24.43%-34.53M | 42.38%-14.65M | 66.47%-45.7M |
| Research and development expenses | ---- | ---- | ---- | ---- | 3.47%-139K | ---281K | ---144K | ---- | ---- | ---- |
| Impairment and provision | 154.23%1.58M | 20.85%-2.3M | -104.21%-2.91M | -87.67%-2.91M | -439.39%-1.42M | -117.75%-1.55M | -102.60%-264K | 178.31%8.73M | 451.89%10.17M | -49.99%-11.15M |
| -Other impairment is provision | 154.23%1.58M | 20.85%-2.3M | -104.21%-2.91M | -87.67%-2.91M | -439.39%-1.42M | -117.75%-1.55M | -102.60%-264K | 178.31%8.73M | 451.89%10.17M | -49.99%-11.15M |
| Special items of operating profit | 256.97%1.44M | 259.67%2.72M | -72.93%402K | -198.42%-1.7M | 352.55%1.49M | -146.80%-570K | -154.95%-588K | 120.97%1.22M | 104.68%1.07M | -162.58%-5.81M |
| Operating profit | 1,014.51%58.45M | 164.57%9.76M | 130.06%5.24M | 47.41%-15.12M | -12.04%-17.44M | -425.59%-28.75M | -154.32%-15.57M | 597.13%8.83M | 280.68%28.66M | -105.80%-1.78M |
| Financing cost | -16.10%-2.76M | 2.99%-5.41M | 31.44%-2.37M | -19.85%-5.58M | -223.46%-3.46M | -923.08%-4.66M | -386.36%-1.07M | 71.79%-455K | 71.05%-220K | -260.85%-1.61M |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---27.44M |
| Earning before tax | 1,839.74%55.69M | 121.01%4.35M | 113.73%2.87M | 38.04%-20.7M | -25.64%-20.91M | -498.87%-33.4M | -158.51%-16.64M | 127.16%8.37M | 271.10%28.44M | -202.15%-30.83M |
| Tax | -1,305.29%-22.6M | -383.66%-1.24M | -396.68%-1.61M | 70.46%-257K | 7,842.86%542K | 89.52%-870K | 99.92%-7K | -73.96%-8.3M | -340.42%-8.39M | 86.46%-4.77M |
| After-tax profit from continuing operations | 2,520.19%33.09M | 114.82%3.11M | 106.20%1.26M | 38.86%-20.95M | -22.33%-20.36M | -48,369.01%-34.27M | -183.02%-16.65M | 100.20%71K | 208.22%20.05M | -600.43%-35.6M |
| After-tax profit from non-continuing business | 359.60%41.25M | -61.93%-44.61M | ---15.89M | ---27.55M | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning after tax | 608.30%74.34M | 14.43%-41.5M | 28.18%-14.63M | -41.52%-48.5M | -22.33%-20.36M | -48,369.01%-34.27M | -183.02%-16.65M | 100.20%71K | 208.22%20.05M | -600.43%-35.6M |
| Minority profit | 74.86%-915K | -35.63%-18.32M | 31.53%-3.64M | -55.79%-13.5M | 15.70%-5.32M | ---8.67M | ---6.31M | ---- | ---- | ---- |
| Shareholders should account for profits from continuing business | 2,592.64%34.01M | 117.68%3.7M | --1.26M | ---20.95M | ---- | ---- | ---- | ---- | ---- | ---- |
| Shareholders should account for profits from non-continuing business | 436.73%41.25M | -91.46%-26.89M | ---12.25M | ---14.05M | ---- | ---- | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | 785.00%75.25M | 33.75%-23.19M | 26.99%-10.99M | -36.69%-35M | -45.52%-15.05M | -36,160.56%-25.6M | -151.58%-10.34M | 100.20%71K | 208.22%20.05M | -600.43%-35.6M |
| Basic earnings per share | 777.78%0.061 | 32.14%-0.019 | 55.00%-0.009 | -33.33%-0.028 | -100.00%-0.02 | -0.021 | -150.00%-0.01 | 0 | 300.00%0.02 | -480.00%-0.029 |
| Diluted earnings per share | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Jindao Liancheng Certified Public Accountants Co., Ltd. | -- | Jindao Liancheng Certified Public Accountants Co., Ltd. | -- | Jindao Liancheng Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.